article thumbnail

Innovation in small molecules: Leading companies in quinoline derivatives as anticancer agents

Pharmaceutical Technology

Zhejiang DTRM Biopharma and Oncore Biopharma stand in second and third positions, respectively. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 92
article thumbnail

Lonza appoints new Chief Executive

European Pharmaceutical Review

Before joining Siegfried in 2010, Wienand worked at the German specialty chemicals company Evonik Industries, Lonza highlighted. Wolfgang Wienand – leading the next chapter “Wolfgang brings a wealth of knowledge and experience to Lonza, complemented by his deep scientific and strategic expertise. billion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eurofins BPT grows Cell & Gene Therapy US Footprint

PharmaTech

Eurofins BioPharma Product Testing (EBPT) in the US is a leading entity in the analytical testing of Cell and Gene Therapy, with its involvement dating back to 2010 at the Eurofins BPT Lancaster, PA location.

article thumbnail

Traditional approaches to growth in biopharma are no longer sustainable

pharmaphorum

Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. And of course, all of this will feed into future treatments and positive patient outcomes – the sole purpose of pharma.

article thumbnail

Innovation in targeted therapies: Leading companies in photodynamic cancer therapy drugs

Pharmaceutical Technology

The company’s lead asset is NBTXR3, which is based on hafnium oxide nanoparticle that is designed to destroy tumors when activated by radiotherapy. ‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Leads 72
article thumbnail

Leading innovators in oxazole derivatives-based cancer drug compositions

Pharmaceutical Technology

Patent volumes related to oxazole derivatives-based cancer drug compositions Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies F. Hoffmann-La Roche is the leading patent filer of oxazole derivatives-based cancer drug compositions.

Leads 52
article thumbnail

Leading innovators in tetrapeptide derivatives for the pharmaceutical industry

Pharmaceutical Technology

Patent volumes related to tetrapeptide derivatives space Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies Amgen 317 Unlock company profile Bristol-Myers Squibb 281 Unlock company profile F. Whilst Abliva and Ambrx Biopharma stand in second and third positions, respectively.